Treatment for Mild Ulcerative Proctitis with Friable Mucosa and Contact Bleeding
Start with rectal 5-ASA suppositories 1 gram daily as first-line therapy for this mild ulcerative proctitis presentation. 1
First-Line Treatment Approach
- Rectal mesalamine suppositories 1 gram once daily are the gold-standard initial therapy for ulcerative proctitis, with strong recommendation and high-quality evidence 1, 2
- This approach is superior to oral 5-ASA alone, rectal corticosteroids, and placebo for inducing both symptomatic and endoscopic remission 1, 3
- Suppositories are better retained than enemas in patients with active proctitis and deliver higher local drug concentrations 1
Combination Therapy if Incomplete Response
If symptoms persist after 2 weeks of rectal therapy alone:
- Add oral mesalamine 2.4-3 grams daily to the suppository regimen 2
- The combination of rectal plus oral 5-ASA is more effective than either alone for distal disease 1
- Continue this combination for a total of 4-8 weeks before declaring treatment failure 1
Second-Line Options for 5-ASA Failure
If no remission after 4-8 weeks of optimized 5-ASA therapy (rectal 1g + oral 4-4.8g daily):
- Add prednisolone 5 mg suppository in the morning while continuing 5-ASA suppository at bedtime 4, 2
- Alternatively, use oral prednisone 40 mg daily (taper over 6-8 weeks) or budesonide MMX 9 mg daily 1
- Rectal corticosteroids are less effective than rectal 5-ASA (odds ratio 1.65 favoring 5-ASA) but can be used as second-line 1, 3
Critical Pitfalls to Avoid
- Never start with corticosteroid suppositories as first-line—they are inferior to 5-ASA and should only be used after 5-ASA failure 1, 4, 2
- Do not continue corticosteroid suppositories beyond 2-4 weeks without reassessment, as prolonged use causes systemic side effects without proven maintenance benefit 4
- Verify adherence and proper insertion technique before escalating therapy—many apparent treatment failures are due to incorrect administration 4
- Exclude alternative diagnoses (infectious colitis, Crohn's disease, solitary rectal ulcer, proximal constipation) if response is inadequate 4
Maintenance Strategy
Once remission is achieved:
- Continue mesalamine suppositories 0.5-1 gram daily for maintenance (can reduce frequency to every 2-3 days) 1, 2
- Alternatively, switch to oral 5-ASA ≥2 grams daily if patient prefers to avoid rectal therapy 1, 2
- Never use corticosteroids for maintenance—they are ineffective and unsafe for long-term use 1, 4
Timeline for Response Assessment
- Evaluate symptomatic response at 2 weeks: rectal bleeding should cease within 7-16 days depending on dose 1
- Formal reassessment at 4-8 weeks: if no complete remission, modify therapy 1
- Consider sigmoidoscopy before systemic therapy escalation to confirm disease extent and rule out proximal extension 4